Table 3 Effect of PA on MI or stroke among male participants stratified by age (OR (95%CI)).
Age | ||||
|---|---|---|---|---|
< 45 | 45–59 | 60–74 | 75– | |
MI | ||||
MPA | 1.397 (0.126–15.460) | 1.965 (0.759–5.088) | 0.731 (0.360–1.486) | 2.097 (0.678–6.493) |
VPA | 0.525 (0.048–5.804) | 0.590 (0.234–1.492) | 0.540 (0.284–1.026) | 1.168 (0.363–3.758) |
Stroke | ||||
MPA | 0.559 (0.149–2.094) | 1.556 (0.869–2.786) | 1.142 (0.773–1.688) | 0.932 (0.515–1.689) |
VPA* | 0.210 (0.056–0.786)** | 0.559 (0.323–0.969)** | 0.631 (0.436–0.914)** | 0.526 (0.283–0.979)** |
MS | ||||
MPA* | 0.582 (0.177–1.920) | 1.809 (1.075–3.043)** | 0.240 (0.197–0.294) | 1.029 (0.596–0.1.776) |
VPA* | 0.263 (0.084–0.818)** | 0.602 (0.366–0.988)** | 0.149 (0.120–0.164)** | 0.578 (0.328–0.1.019)* |